Global Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial), Regional Forecasts 2021-2027
Global Vaccine Adjuvants Market is valued approximately at USD 0.70 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2021-2027. Vaccine adjuvant is an immunological agent that helps in the modification of other agents' effects. It is included in the vaccination to boost the immune response and provide long-lasting protection against the antigen. Adjuvants are added to vaccines to improve the body's response to vaccination while also reducing the number of vaccine doses given to patients. Aluminum hydroxide and paraffin oil are the most often utilized adjuvants. Vaccine adjuvant also decreases the quantity of administered foreign material. It has also been used in research and for commercial purposes. The market growth is driven by high prevalence of infectious and zoonotic diseases and increasing focus on immunization programs from various government bodies. For instance, various governmental organizations across the globe are promoting and creating awareness about vaccination against diseases such as anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other illnesses. The US government provided USD 290 million in foreign aid to the Global Alliance for Vaccines and Immunization (GAVI, now known as GAVI, the Vaccine Alliance) in 2019 and USD 226 million to the Department of Health and Human Services (HHS) to support child vaccine campaigns in other countries. However, stringent regulatory environment and time-consuming approvals may impede market growth over the forecast period of 2021-2027.
A rise in investments for R&D of novel medicines, as well as an increase in deadly epidemic illnesses, are driving the vaccine adjuvants market in the North American area. As a result, vaccination against acute and chronic illnesses is required. In addition, the existence of significant market participants in the United States increases product penetration. Adjuvance Technologies, Inc., for example, has created a portfolio of adjuvants for the treatment of a variety of diseases.
Major market player included in this report are:
SPI Pharma, Inc.
Brenntag Biosector A/S
Seppic
CSL Limited
Agenus, Inc.
Novavax, Inc.
Invivogen
SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
Avanti Polar Lipids, Inc.
MVP Laboratories, Inc.
OZ Biosciences
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product type:
Pathogen Components
Adjuvant Emulsions
Particulate Adjuvants
Combination Adjuvants
Others
By Route of administration:
Oral
Subcutaneous
Intranasal
Intramuscular
Intradermal
Others
By Application:
Research Applications
Commercial Applications
By Disease type:
Infectious Diseases
Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Vaccine Adjuvants Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
A rise in investments for R&D of novel medicines, as well as an increase in deadly epidemic illnesses, are driving the vaccine adjuvants market in the North American area. As a result, vaccination against acute and chronic illnesses is required. In addition, the existence of significant market participants in the United States increases product penetration. Adjuvance Technologies, Inc., for example, has created a portfolio of adjuvants for the treatment of a variety of diseases.
Major market player included in this report are:
SPI Pharma, Inc.
Brenntag Biosector A/S
Seppic
CSL Limited
Agenus, Inc.
Novavax, Inc.
Invivogen
SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
Avanti Polar Lipids, Inc.
MVP Laboratories, Inc.
OZ Biosciences
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product type:
Pathogen Components
Adjuvant Emulsions
Particulate Adjuvants
Combination Adjuvants
Others
By Route of administration:
Oral
Subcutaneous
Intranasal
Intramuscular
Intradermal
Others
By Application:
Research Applications
Commercial Applications
By Disease type:
Infectious Diseases
Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Vaccine Adjuvants Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Vaccine Adjuvants Market, by Region, 2019-2027 (USD Billion)
1.2.2. Vaccine Adjuvants Market, by Product type, 2019-2027 (USD Billion)
1.2.3. Vaccine Adjuvants Market, by Route of administration, 2019-2027 (USD Billion)
1.2.4. Vaccine Adjuvants Market, by Application, 2019-2027 (USD Billion)
1.2.5. Vaccine Adjuvants Market, By Disease type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL VACCINE ADJUVANTS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL VACCINE ADJUVANTS MARKET DYNAMICS
3.1. Vaccine Adjuvants Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High prevalence of infectious and zoonotic diseases
3.1.1.2. Increasing focus on immunization programs from various government bodies
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory environment and time-consuming approvals
3.1.2.2. High cost of adjuvant research
3.1.3. Market Opportunities
3.1.3.1. Pandemic diseases
3.1.3.2. Combination adjuvants
CHAPTER 4. GLOBAL VACCINE ADJUVANTS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Product type, Performance - Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Product type 2018-2027 (USD Billion)
5.4. Vaccine Adjuvants Market , Sub Segment Analysis
5.4.1. Pathogen Components
5.4.2. Adjuvant Emulsions
5.4.3. Particulate Adjuvants
5.4.4. Combination Adjuvants
5.4.5. Others
CHAPTER 6. GLOBAL VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION
6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Route of Administration, Performance - Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Route of administration 2018-2027 (USD Billion)
6.4. Vaccine Adjuvants Market , Sub Segment Analysis
6.4.1. Oral
6.4.2. Subcutaneous
6.4.3. Intranasal
6.4.4. Intramuscular
6.4.5. Intradermal
6.4.6. Others
CHAPTER 7. GLOBAL VACCINE ADJUVANTS MARKET, BY DISEASE TYPE
7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Disease type, Performance - Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Disease type 2018-2027 (USD Billion)
7.4. Vaccine Adjuvants Market , Sub Segment Analysis
7.4.1. Research Applications
7.4.2. Commercial Applications
CHAPTER 8. GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Vaccine Adjuvants Market by Application, Performance - Potential Analysis
8.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
8.4. Vaccine Adjuvants Market , Sub Segment Analysis
8.4.1. Research and Development
8.4.2. Clinical Diagnostics
CHAPTER 9. GLOBAL VACCINE ADJUVANTS MARKET, REGIONAL ANALYSIS
9.1. Vaccine Adjuvants Market , Regional Market Snapshot
9.2. North America Vaccine Adjuvants Market
9.2.1. U.S. Vaccine Adjuvants Market
9.2.1.1. Product type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027
9.2.1.3. Disease type breakdown estimates & forecasts, 2018-2027
9.2.1.4. Application breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Vaccine Adjuvants Market
9.3. Europe Vaccine Adjuvants Market Snapshot
9.3.1. U.K. Vaccine Adjuvants Market
9.3.2. Germany Vaccine Adjuvants Market
9.3.3. France Vaccine Adjuvants Market
9.3.4. Spain Vaccine Adjuvants Market
9.3.5. Italy Vaccine Adjuvants Market
9.3.6. Rest of Europe Vaccine Adjuvants Market
9.4. Asia-Pacific Vaccine Adjuvants Market Snapshot
9.4.1. China Vaccine Adjuvants Market
9.4.2. India Vaccine Adjuvants Market
9.4.3. Japan Vaccine Adjuvants Market
9.4.4. Australia Vaccine Adjuvants Market
9.4.5. South Korea Vaccine Adjuvants Market
9.4.6. Rest of Asia Pacific Vaccine Adjuvants Market
9.5. Latin America Vaccine Adjuvants Market Snapshot
9.5.1. Brazil Vaccine Adjuvants Market
9.5.2. Mexico Vaccine Adjuvants Market
9.6. Rest of The World Vaccine Adjuvants Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. SPI Pharma, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Brenntag Biosector A/S
10.2.3. Seppic
10.2.4. CSL Limited
10.2.5. Agenus, Inc.
10.2.6. Novavax, Inc.
10.2.7. Invivogen
10.2.8. SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
10.2.9. Avanti Polar Lipids, Inc.
10.2.10. MVP Laboratories, Inc.
10.2.11. OZ Biosciences
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Vaccine Adjuvants Market, by Region, 2019-2027 (USD Billion)
1.2.2. Vaccine Adjuvants Market, by Product type, 2019-2027 (USD Billion)
1.2.3. Vaccine Adjuvants Market, by Route of administration, 2019-2027 (USD Billion)
1.2.4. Vaccine Adjuvants Market, by Application, 2019-2027 (USD Billion)
1.2.5. Vaccine Adjuvants Market, By Disease type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL VACCINE ADJUVANTS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL VACCINE ADJUVANTS MARKET DYNAMICS
3.1. Vaccine Adjuvants Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High prevalence of infectious and zoonotic diseases
3.1.1.2. Increasing focus on immunization programs from various government bodies
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory environment and time-consuming approvals
3.1.2.2. High cost of adjuvant research
3.1.3. Market Opportunities
3.1.3.1. Pandemic diseases
3.1.3.2. Combination adjuvants
CHAPTER 4. GLOBAL VACCINE ADJUVANTS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Product type, Performance - Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Product type 2018-2027 (USD Billion)
5.4. Vaccine Adjuvants Market , Sub Segment Analysis
5.4.1. Pathogen Components
5.4.2. Adjuvant Emulsions
5.4.3. Particulate Adjuvants
5.4.4. Combination Adjuvants
5.4.5. Others
CHAPTER 6. GLOBAL VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION
6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Route of Administration, Performance - Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Route of administration 2018-2027 (USD Billion)
6.4. Vaccine Adjuvants Market , Sub Segment Analysis
6.4.1. Oral
6.4.2. Subcutaneous
6.4.3. Intranasal
6.4.4. Intramuscular
6.4.5. Intradermal
6.4.6. Others
CHAPTER 7. GLOBAL VACCINE ADJUVANTS MARKET, BY DISEASE TYPE
7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Disease type, Performance - Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Disease type 2018-2027 (USD Billion)
7.4. Vaccine Adjuvants Market , Sub Segment Analysis
7.4.1. Research Applications
7.4.2. Commercial Applications
CHAPTER 8. GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Vaccine Adjuvants Market by Application, Performance - Potential Analysis
8.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
8.4. Vaccine Adjuvants Market , Sub Segment Analysis
8.4.1. Research and Development
8.4.2. Clinical Diagnostics
CHAPTER 9. GLOBAL VACCINE ADJUVANTS MARKET, REGIONAL ANALYSIS
9.1. Vaccine Adjuvants Market , Regional Market Snapshot
9.2. North America Vaccine Adjuvants Market
9.2.1. U.S. Vaccine Adjuvants Market
9.2.1.1. Product type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027
9.2.1.3. Disease type breakdown estimates & forecasts, 2018-2027
9.2.1.4. Application breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Vaccine Adjuvants Market
9.3. Europe Vaccine Adjuvants Market Snapshot
9.3.1. U.K. Vaccine Adjuvants Market
9.3.2. Germany Vaccine Adjuvants Market
9.3.3. France Vaccine Adjuvants Market
9.3.4. Spain Vaccine Adjuvants Market
9.3.5. Italy Vaccine Adjuvants Market
9.3.6. Rest of Europe Vaccine Adjuvants Market
9.4. Asia-Pacific Vaccine Adjuvants Market Snapshot
9.4.1. China Vaccine Adjuvants Market
9.4.2. India Vaccine Adjuvants Market
9.4.3. Japan Vaccine Adjuvants Market
9.4.4. Australia Vaccine Adjuvants Market
9.4.5. South Korea Vaccine Adjuvants Market
9.4.6. Rest of Asia Pacific Vaccine Adjuvants Market
9.5. Latin America Vaccine Adjuvants Market Snapshot
9.5.1. Brazil Vaccine Adjuvants Market
9.5.2. Mexico Vaccine Adjuvants Market
9.6. Rest of The World Vaccine Adjuvants Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. SPI Pharma, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Brenntag Biosector A/S
10.2.3. Seppic
10.2.4. CSL Limited
10.2.5. Agenus, Inc.
10.2.6. Novavax, Inc.
10.2.7. Invivogen
10.2.8. SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
10.2.9. Avanti Polar Lipids, Inc.
10.2.10. MVP Laboratories, Inc.
10.2.11. OZ Biosciences
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Vaccine Adjuvants Market, report scope
TABLE 2. Global Vaccine Adjuvants Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Vaccine Adjuvants Market estimates & forecasts by Product type 2018-2027 (USD Billion)
TABLE 4. Global Vaccine Adjuvants Market estimates & forecasts by Route of administration 2018-2027 (USD Billion)
TABLE 5. Global Vaccine Adjuvants Market estimates & forecasts by Disease type 2018-2027 (USD Billion)
TABLE 6. Global Vaccine Adjuvants Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 7. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South KoreaVaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of Global Vaccine Adjuvants Market.
TABLE 78. List of primary sources used in the study of Global Vaccine Adjuvants Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
TABLE 1. Global Vaccine Adjuvants Market, report scope
TABLE 2. Global Vaccine Adjuvants Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Vaccine Adjuvants Market estimates & forecasts by Product type 2018-2027 (USD Billion)
TABLE 4. Global Vaccine Adjuvants Market estimates & forecasts by Route of administration 2018-2027 (USD Billion)
TABLE 5. Global Vaccine Adjuvants Market estimates & forecasts by Disease type 2018-2027 (USD Billion)
TABLE 6. Global Vaccine Adjuvants Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 7. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South KoreaVaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of Global Vaccine Adjuvants Market.
TABLE 78. List of primary sources used in the study of Global Vaccine Adjuvants Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
LIST OF FIGURES
FIG 1. Global Vaccine Adjuvants Market, research methodology
FIG 2. Global Vaccine Adjuvants Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Vaccine Adjuvants Market, key trends 2020
FIG 5. Global Vaccine Adjuvants Market, growth prospects 2021-2027
FIG 6. Global Vaccine Adjuvants Market, porters 5 force model
FIG 7. Global Vaccine Adjuvants Market, pest analysis
FIG 8. Global Vaccine Adjuvants Market, value chain analysis
FIG 9. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Vaccine Adjuvants Market, regional snapshot 2018 & 2027
FIG 18. North America Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 19. Europe Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 22. Global Vaccine Adjuvants Market, company market share analysis (2020)
FIG 1. Global Vaccine Adjuvants Market, research methodology
FIG 2. Global Vaccine Adjuvants Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Vaccine Adjuvants Market, key trends 2020
FIG 5. Global Vaccine Adjuvants Market, growth prospects 2021-2027
FIG 6. Global Vaccine Adjuvants Market, porters 5 force model
FIG 7. Global Vaccine Adjuvants Market, pest analysis
FIG 8. Global Vaccine Adjuvants Market, value chain analysis
FIG 9. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Vaccine Adjuvants Market, regional snapshot 2018 & 2027
FIG 18. North America Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 19. Europe Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
FIG 22. Global Vaccine Adjuvants Market, company market share analysis (2020)
